This is a preview of subscription content, log in via an institution to check access.
References
Mayor's Committee on Marihuana,The marihuana Problem in the City of New York. Sociological, Medical. Psychological, and Pharmacological Studies (Jacques Cattell Press, Lancaster, Pennsylvania 1944).
H. Isbell, C. W. Gorodetzsky, D. Jasinski, U. Claussen, F. v. Spulak andF. Korte,Effects of (−) β 9 -Trans-Tetrahydrocannabinol in Man, Psychopharmacologica11, 184–188 (1967).
R. Adams, M. Harfenst andS. Loewe,New Analogs of Tetrahydrocannabinol XIX, J. Am. Chem. Soc.71, 1624–1628 (1949).
Y. Gaoni andJ. Mechoulam,Hashish III. The Isolation, Structure Partial Synthesis of an Active Constituent of Hashish, J. Am. Chem. Soc.86, 1646 to 1647 (1964).
F. Korte, M. Haag andU. Claussen,Tetrahydrocannabinolcarboxylic Acid, a Component of Hashish, Angew. Chem. (Intern. Ed.)4, 872 (1965).
E. C. Taylor, K. Lenard andY. Shvo,Active Constituents of Hashish. Synthesis of dl-β 6 -3, 4, Trans-Tetrahydrocannabinol, J. Am. Chem. Soc.88, 367–369 (1966).
D. E. Fahrenholtz, M. Lurie andR. W. Kierstead The Total Synthesis of dl-β 9 -Tetrahydrocannabinol and of dl-β- 8 -Tetrahydrocannabinol Racemates of Active Constituents of Marihuana, J. Am. Chem. Soc.88, 2079–2080 (1966).
Y. Gaoni andJ. Mechoulam,Hashish IX. Concerning the Isomerization of β 1 -to β 1 { 6 }-Tetrahydrocannabinol,88, 5673–5675 (1966).
S. Loewe,Studies on the Pharmacology and Acute Toxicity of Compounds with Marihuana Activity, J. Pharmac. exp. Ther.88, 1954–1961 (1946).
T. P. Davis andH. H. Ramsey,Antiepileptic Action of Marihuana Active Substances, Fedn Proc.8, 284–285 (1949).
S. Loewe andL. S. Goodman,Anticonvulsant Action of Marihuana-Like Substances, Fedn Proc.6, 352 (1947).
S. Loewe,Cannabiswirkstoffe und Pharmakologie der Kannabinole, Arch. exp. Path. Pharmak.211, 175–193 (1950).
R. Dagirmanjian andE. S. Boyd,Some Pharmacological Effects of Two Tetrahydrocannabinols, J. Pharmac. exp. Ther.135, 25–33 (1962).
C. A. M. Sampaio, A. J. Lapa andJ. R. Valle,Influence of Cannabis Tetrahydrocannabinol and Parahexylon the Linguomandibular Reflex of Dog, J. Pharm. Pharmac.19, 552–554 (1967).
S. Loewe,Synergism of Cannabis and Butyl-bromoallylbarbituric Acid, J. Am. Pharm. Ass. Sci. Ed.29, 162–163 (1940).
J. C. Garriott, L. J. King, R. B. Forney andF. W. Hughes,Effects of Some Tetrahydrocannabinols on Sleeping Time and Amphetamine Induced Hyperactivity in Mice, Life Sci.6, 2119–2128 (1967).
E. S. Boyd, E. D. Hutchinson, L. C. Gardner andD. A. Meritt,Effects of Tetrahydrocannabinols and Other Drugs on Operant Behavior in Rats, Arch. Int. Pharmacodyn. Ther.144, 533–554 (1963).
E. S. Boyd andD. A. Meritt,Effects of Thiopental and a Tetrahydrocannabinol Derivative of Arousal and Recruiting in the Cat, J. Pharmac. exp. Ther.149, 138–145 (1965).
E. S. Boyd andD. A. Meritt,Effects of Barbiturates and a Tetrahydrocannabinol Derivative on Recovery Cycles of Medial Lemniscus, Thalamus and Reticular Formation in the Cat, J. Pharmac. exp. Ther.151, 376 to 384 (1966).
H. J. Bein,The Pharmacology of Rauwolfia, Pharmac. Rev.8, 435–483 (1956).
J. J. Lewis,Rauwolfia Alkaloids, J. Pharm. Pharmac.8, 465–494 (1956).
H. J. Bein,Zur Pharmakologie der Reserpine eines neuen Alkaloids aus Rauwolfia serpentina Benth., Experientia9, 107–110 (1953).
J. H. Trapold, A. J. Plummer andF. F. Yonkman,Cardiovascular and Respiratory Effects of Serpasil, a New Crystalline Alkaloid from Serpentina Benth. in the Dog, J. Pharmac. exp. Ther.110, 205–214 (1954).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dagirmanjian, R., Hodge, H.C. Are biogenic amines involved in the mechanism of action of the tetrahydrocannabinols?. Agents and Actions 1, 46–48 (1969). https://doi.org/10.1007/BF01977666
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01977666